首页> 外文期刊>The journal of sexual medicine >Short- and Long-Term Clinical Skin Effects of Testosterone Treatment in Trans Men
【24h】

Short- and Long-Term Clinical Skin Effects of Testosterone Treatment in Trans Men

机译:跨性别男性睾丸激素治疗的短期和长期临床皮肤影响

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Our knowledge concerning the effects of testosterone (T) therapy on the skin of trans men (female-to-male transsexuals) is scarce. Aim: The aim of this study was to evaluate the short- and long-term clinical effects of T treatment on the skin of trans men. Methods: We conducted a prospective intervention study in 20 hormone naive trans men and a cross-sectional study in 50 trans men with an average of 10 years on T therapy. Main Outcome Measures: Acne lesions were assessed using the Gradual Acne Grading Scale, hair patterns using the Ferriman and Gallwey classification (F&G), and androgenetic alopecia using the Norwood Hamilton Scale. Results: T treatment increased facial and body hair growth. The F&G score increased progressively from a median value of 0.5 at baseline to a value of 12 after 12 months of T administration. After long-term T treatment, all but one trans man achieved an F&G score indicative of hirsutism in women, with a median value of 24. Only one trans man acquired mild frontotemporal hair loss during the first year of T treatment, whereas 32.7% of trans men had mild frontotemporal hair loss and 31% had moderate to severe androgenetic alopecia after long-term T therapy. The presence and severity of acne increased during the first year of T therapy, and peaked at 6 months. After long-term T treatment, most participants had no or mild acne lesions (93.9%). Dermatological outcome was not demonstrably related to individual serum T or dihydrotestosterone levels. Conclusions: T treatment increased facial and body hair in a time-dependent manner. The prevalence and severity of acne in the majority of trans men peaked 6 months after beginning T therapy. Severe skin problems were absent after short- and long-term T treatment.
机译:简介:我们对睾丸激素(T)治疗对跨性别者(男性至男性变性者)皮肤的影响的了解很少。目的:本研究的目的是评估T治疗对跨性别男人皮肤的短期和长期临床效果。方法:我们对20位激素初次接受治疗的跨性别男人进行了一项前瞻性干预研究,并对50位平均接受T治疗10年的跨性别男人进行了横断面研究。主要结局指标:使用渐进痤疮分级量表评估痤疮病变,使用Ferriman和Gallwey分类(F&G)评估头发类型,并使用Norwood Hamilton量表评估雄激素性脱发。结果:T治疗可增加面部和身体毛发生长。 F&G评分从基线的中位数0.5逐渐增加到T给药12个月后的12。经过长期的T治疗后,除一名跨性别男人外,所有其他跨性别者均获得F&G评分,表明女性多毛症,中位值为24。只有一名跨性别男人在T治疗的第一年出现额颞叶轻度脱发,而其中32.7%在长期T治疗后,跨性别者轻度额颞脱发,31%患有中度至重度雄​​激素性脱发。在T治疗的第一年,痤疮的出现和严重程度增加,并在6个月达到高峰。经过长期的T治疗后,大多数参与者没有或有轻度痤疮病变(93.9%)。皮肤病学结局与个体血清T或二氢睾丸激素水平无明显关系。结论:T治疗以时间依赖性方式增加面部和体毛。在大多数T型男性中,痤疮的患病率和严重程度在开始T治疗后6个月达到峰值。短期和长期的T治疗后,没有出现严重的皮肤问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号